Skip to main content
Erschienen in: Lasers in Medical Science 3/2022

17.10.2021 | Original Article

Factors affecting the response to subthreshold micropulse laser therapy used in center-involved diabetic macular edema

verfasst von: Mehmed Uğur Işık, Mehmet Fatih Kağan Değirmenci, Ayhan Sağlık

Erschienen in: Lasers in Medical Science | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to investigate the effect of the status of retinal pigment epithelium (RPE) and HbA1c levels on the efficacy of the subthreshold micropulse laser (SMPL) in the treatment of center-involving diabetic macular edema (DME). A total of 20 eyes of 20 patients (mean age 57.9 ± 9.7 years) who were diagnosed with center-involving DME and treated with SMPL for refusing intravitreal injection and 20 eyes of 20 age- and sex-matched healthy participants were enrolled. All patients were followed up in the 1st and 3rd months after SMPL. For measurement of RPE area central 1000 microns, macular EDI-OCT scans were binarized by using the public domain software ImageJ, with a semi-automated technique. There was a significant increase in BCVA values and a significant decrease in CMT values during follow-up. The area of RPE before SMPL was significantly thinner in the patient group (p: 0.004). When the areas of RPE before and 3 months after SMPL were compared, no significant change was observed (p: 0.437). When the relationship between pre-treatment area of RPE and HbA1c was examined, an inverse correlation was observed (p: 0.018). The patients were evaluated by dividing them into 2 groups as 2nd session SMPL required and not required, and the area of RPE was smaller in the group requiring 2nd session SMPL (p: 0.030). The status of central RPE may be a determining factor on the response to treatment. Additionally, HbA1c levels may have an impact on treatment efficacy.
Literatur
2.
Zurück zum Zitat (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 103(12):1796–806 (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 103(12):1796–806
3.
Zurück zum Zitat (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl):766–85 (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl):766–85
8.
Zurück zum Zitat Figueira J, Khan J, Nunes S, Sivaprasad S, Rosa A, de Abreu JF et al (2009) Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 93(10):1341–1344. https://doi.org/10.1136/bjo.2008.146712CrossRefPubMed Figueira J, Khan J, Nunes S, Sivaprasad S, Rosa A, de Abreu JF et al (2009) Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol 93(10):1341–1344. https://​doi.​org/​10.​1136/​bjo.​2008.​146712CrossRefPubMed
9.
Zurück zum Zitat Vujosevic S, Toma C, Villani E, Brambilla M, Torti E, Leporati F et al (2020) Subthreshold micropulse laser in diabetic macular edema: 1-year improvement in OCT/OCT-angiography biomarkers. Transl Vis Sci Technol 9(10):31-CrossRefPubMedPubMedCentral Vujosevic S, Toma C, Villani E, Brambilla M, Torti E, Leporati F et al (2020) Subthreshold micropulse laser in diabetic macular edema: 1-year improvement in OCT/OCT-angiography biomarkers. Transl Vis Sci Technol 9(10):31-CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44(8):968–83 (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44(8):968–83
14.
Zurück zum Zitat (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131):837–53 (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131):837–53
16.
23.
Zurück zum Zitat Vinores SA, Gadegbeku C, Campochiaro PA, Green WR (1989) Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol 134(2):231–235PubMedPubMedCentral Vinores SA, Gadegbeku C, Campochiaro PA, Green WR (1989) Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol 134(2):231–235PubMedPubMedCentral
Metadaten
Titel
Factors affecting the response to subthreshold micropulse laser therapy used in center-involved diabetic macular edema
verfasst von
Mehmed Uğur Işık
Mehmet Fatih Kağan Değirmenci
Ayhan Sağlık
Publikationsdatum
17.10.2021
Verlag
Springer London
Erschienen in
Lasers in Medical Science / Ausgabe 3/2022
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-021-03441-8

Weitere Artikel der Ausgabe 3/2022

Lasers in Medical Science 3/2022 Zur Ausgabe